微生物天然产物的合成生物学与新药开发
2008-2009 深圳一致药业集团致君制药有限公司,QA
2016-2022 英国华威大学,博士后
2022-至今 中国科学院微生物研究所,研究员
2021,入选国家海外高层次青年人才引进计划
2021,入选国家优秀自费留学生奖学金B类
2021,获英国华威大学Faculty of Science, Engineering and Medicine Post-Doctoral Research Prize in Chemistry
2016,获英国EPSRC Early Career Fellowship支持
2012-2016,英国华威大学Chancellor’s International Scholarship和BBSRC博士全额奖学金
微生物能够产生结构多样和活性丰富的次级代谢产物,是现代药物发现和创新的重要源泉。本课题组针对微生物天然产物开展化学和生物学等多领域交叉研究,研究内容主要包含以下方面:1.微生物活性天然产物的发现、结构改造与新药研发;2.微生物次级代谢产物的生物合成及其调控与合成生物学应用
1.Zhou S#, Bhukya H#, Malet NR#, Harrison PJ, Rea D, Belousoff MJ, Venugopal H, Sydor PK, Styles KM, Song L, Cryle MJ, Alkhalaf LM, Fülöp V, Challis GL*, Corre C*. Molecular basis for control of antibiotic production by a bacterial hormone. Nature 2021, 590: 463-467.
2. Zhou S, Malet NR, Song L, Corre C, Challis GL*. MmfL catalyses formation of a phosphorylated butenolide intermediate in methylenomycin furan biosynthesis. Chem. Commun. 2020, 56: 14443-14446.
3. Kosol S#, Gallo A#, Griffiths D#, Valentic TR#, Masschelein J, Jenner M, de los Santos ELC, Manzi L, Sydor PK, Rea D, Zhou S, Fulop V, Oldham NJ, Tsai S-C, Challis GL*, Lewandowski JR*. Structural basis for chain release from the enacyloxin polyketide synthase. Nat. Chem. 2019, 11: 913-923.
4. Zhou S, Song L, Masschelein J, Sumang FAM, Papa IA, Zulaybar TO, Custodio AB, Zabala D, Alcantara EP, de los Santos ELC*, Challis GL*. Pentamycin biosynthesis in Philippine Streptomyces sp. S816: cytochrome P450-catalyzed installation of the C-14 hydroxyl group. ACS Chem. Biol. 2019, 14: 1305-1309.
5. Inahashi Y#, Zhou S#, Bibb MJ, Song L, Al-Bassam MM, Bibb MJ*, Challis GL*. Watasemycin biosynthesis in Streptomyces venezuelae: thiazoline C-methylation by a type B radical-SAM methylase homologue. Chem. Sci. 2017, 8: 2823-2831.
6. Zhou S, Alkhalaf LM, de los Santos ELC, Challis GL*. Mechanistic insights into class B radical-S-adenosylmethionine methylases: Ubiquitous tailoring enzymes in natural product biosynthesis. Curr. Opin. Chem. Biol. 2016, 35: 73-79.
7. Wang R#, Zhang X#, Song H, Zhou S, Li S*. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents. Bioorg. Med. Chem. Lett. 2014, 24: 4304-4307.
8. Song H, Zhou S, Wang R*, Li S*. Kinesin spindle protein (KSP) inhibitors in combination with chemotherapeutic agents for cancer therapy. ChemMedChem 2013, 8: 1736-1749.
9. Wang R, Zhou S, Jiang H, Zheng X, Zhou W, Li S*. An efficient multigram synthesis of alkannin and shikonin. Eur. J. Org. Chem. 2012, 7: 1373-1379.
10. Wang R, Zhou S, Li S*. Cancer therapeutic agents targeting hypoxia-inducible factor-1. Curr. Med. Chem. 2011, 18: 3168-3189.
1、国家重点研发计划-“合成生物学”专项 (2025-2029)
2、国家重点研发计划-“前沿生物技术”专项 (2024-2028)
3、国家自然科学基金-面上项目 (2025-2028)
4、国家自然科学基金-面上项目 (2023-2026)
5、国家自然科学基金-青年项目 (张瑞飞,2024-2026)
6、中国博士后科学基金-博士后第74批面上资助 (张瑞飞,2024-2025)